Ophthalmology
News, opinions and meeting coverage in ophthalmology.
— Significant improvement in BCVA versus historical declines, 75% decrease in new-onset cases
Latest in Ophthalmology
Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients
Higher rates of progression, interventions, systemic events versus retinopathy without apnea
Significantly lower risk of diabetic macular edema, proliferative diabetic retinopathy
But the trial was halted when the funder changed its business focus
Significantly lower risk of diabetic macular edema, proliferative diabetic retinopathy
But the trial was halted when the funder changed its business focus
Ophthalmology Case Studies
Tropical parasitic disease is often asymptomatic, but beware of unexplained ocular symptoms
Case highlights risk-benefit considerations with concurrent bilateral intravitreal injections
Authors discuss how best to diagnose and manage him, given the absence of any symptoms
More in Ophthalmology
Propensity-matched analysis favored the C3 inhibitor over avacincaptad pegol at 12 and 24 months
Studies show 90% reduction in intravitreal treatment burden, durable effect on vision, anatomy
Plastic surgery and ophthalmology top the list
Claims data point to possible protective effect for one common drug class
Updates to device, refill syringe, manufacturing process restore function to expected level
Improved visual acuity, lower prevalence of biomarkers of progressive disease in second eye
Association with optic neuropathy in observational data needs further study to assess causality
Use of steroid eye drops, methotrexate appeared to be risk factors
"There are more supportive measures we can take without resorting to antibiotic eye drops"
While insurers rarely reject requests, they can take weeks to approve anti-VEGF injections
Randomized trial shows a benefit of an inexpensive cholesterol drug
Infections were extremely rare when surgeons relied only on low-strength povidone iodine
Also in TTHealthWatch: cancers subsequent to CAR-T therapy
No loss in visual acuity, with reduced cost of treatment
